Literature DB >> 34980989

Facial Diplegia with Preserved Reflexes: An Unusual Case of Anti-GD1b Antibody Associated Guillain-Barré Syndrome.

Riwaj Bhagat1, Martin Brown1.   

Abstract

Anti-ganglioside D1b (GD1b) Immunoglobulin G (IgG) positive Guillain-Barré Syndrome (GBS) is rare and usually presents with acute sensory or cerebellar ataxia, ascending paralysis, and loss of deep tendon reflexes (DTRs). A 19-year-old female individual with recent Influenza A infection had an acute onset of facial diplegia and minimal leg weakness with preserved DTRs. Cerebrospinal fluid analysis showed albuminocytologic dissociation with positive serum anti-GD1b IgG antibody (52 IV; reference range 0-50). Magnetic resonance imaging of the cervical spine showed nerve root enhancement. Following intravenous immunoglobulin therapy and subsequent physiotherapy, the patient reached the nadir of leg weakness by one month and had complete motor recovery after one year. Sensory ataxia was observed in the fourth month of the illness, which subsided by eight months. DTRs were normal throughout the course of the disease. This case showed an unusual evolution of GBS with a positive anti-GD1b antibody presenting with acute facial diplegia, normal DTR and delayed sensory ataxia.
Copyright © 2021. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Facial diplegia; GBS; GD1b antibody

Year:  2021        PMID: 34980989      PMCID: PMC8667697     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  13 in total

Review 1.  Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies.

Authors:  S Kusunoki
Journal:  Am J Med Sci       Date:  2000-04       Impact factor: 2.378

2.  Ataxic form of Guillain-Barr syndrome associated with anti-GD1b IgG antibody.

Authors:  N Yuki; K Susuki; K Hirata
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

3.  A case of Guillain-Barré syndrome associated with cerebellar ataxia and positive serum anti-GD1b IgG antibody.

Authors:  Hideki Sugimoto; Nobuo Wakata; Masahiko Kishi; Toshiki Fujioka; Teruyuki Kurihara; Yukiko Irie; Toyokazu Saito
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

4.  Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection.

Authors:  B S Simpson; Y A Rajabally
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

Review 5.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

Review 6.  Corticosteroids for Guillain-Barré syndrome.

Authors:  Richard Ac Hughes; Ruth Brassington; Angela A Gunn; Pieter A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2016-10-24

7.  Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.

Authors:  David N Juurlink; Therese A Stukel; Jeffrey Kwong; Alexander Kopp; Allison McGeer; Ross E Upshur; Douglas G Manuel; Rahim Moineddin; Kumanan Wilson
Journal:  Arch Intern Med       Date:  2006-11-13

Review 8.  Guillain-Barré syndrome after exposure to influenza virus.

Authors:  Helmar C Lehmann; Hans-Peter Hartung; Bernd C Kieseier; Richard A C Hughes
Journal:  Lancet Infect Dis       Date:  2010-09       Impact factor: 25.071

9.  Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature.

Authors:  J R Keane
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

10.  GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.

Authors:  K Kaida; K Kamakura; G Ogawa; M Ueda; K Motoyoshi; M Arita; S Kusunoki
Journal:  Neurology       Date:  2008-07-15       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.